Literature DB >> 21266388

Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes.

Nikki J Kerruish1.   

Abstract

Advances in genomic medicine have lead to debate about the potential inclusion of genetic tests for susceptibility to common complex disorders in newborn screening programmes. Empirical evidence concerning psychosocial reactions to genetic testing is a crucial component of both ethical debate and policy development, but while there has been much speculation concerning the possible psychosocial impact of screening newborns for genetic susceptibilities, there remains a paucity of data. The aim of the study reported here is to provide some of this missing empirical evidence, using type 1 diabetes as an example of a common disorder with multiple significant genetic contributors to its aetiology. Semi-structured interviews were conducted with 11 parents of babies who had received increased risk results in a study that involved newborn screening for genetic susceptibility to type 1 diabetes. Interpretative phenomenological analysis was used to evaluate the data. The interview data suggest that the probabilistic nature of results of genetic susceptibility tests impacts upon all aspects of parents' psychosocial reactions, resulting in a complex and dynamic process quite different to that described in relation to current newborn screening programmes. While parents generally reported fairly minor levels of concern in response to news of their child's increased genetic risk, these worries frequently recurred, and perception of risk also varied and fluctuated over time. Both individual and contextual factors appeared to interact with the inherent uncertainty of the test result to contribute to the dynamic nature of parental reactions, and their behavioural responses. The implications of these findings for future research and for the debate concerning potential expansion of newborn screening are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21266388     DOI: 10.1136/jme.2010.039206

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  9 in total

1.  Public attitudes towards genomic risk profiling as a component of routine population screening.

Authors:  S G Nicholls; B J Wilson; S M Craigie; H Etchegary; D Castle; J C Carroll; B K Potter; L Lemyre; J Little
Journal:  Genome       Date:  2013-08-31       Impact factor: 2.166

Review 2.  Psychological impact of screening and prediction in type 1 diabetes.

Authors:  Suzanne Bennett Johnson
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

3.  Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes.

Authors:  Nicola J Kerruish; Dione M Healey; Andrew R Gray
Journal:  Eur J Hum Genet       Date:  2017-01-25       Impact factor: 4.246

4.  Psychosocial impact on mothers receiving expanded newborn screening results.

Authors:  Kathleen O'Connor; Tara Jukes; Sharan Goobie; Jennifer DiRaimo; Greg Moran; Beth Katherine Potter; Pranesh Chakraborty; Charles Anthony Rupar; Srinitya Gannavarapu; Chitra Prasad
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

5.  Expectations and values about expanded newborn screening: a public engagement study.

Authors:  Robin Z Hayeems; Fiona A Miller; Yvonne Bombard; Denise Avard; June Carroll; Brenda Wilson; Julian Little; Pranesh Chakraborty; Jessica Bytautas; Yves Giguere; Judith Allanson; Renata Axler
Journal:  Health Expect       Date:  2013-02-01       Impact factor: 3.377

6.  Parents' experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns.

Authors:  Nicola Kerruish
Journal:  Genet Med       Date:  2015-06-11       Impact factor: 8.822

Review 7.  Absorbing it all: A meta-ethnography of parents' unfolding experiences of newborn screening.

Authors:  Ashley L White; Felicity Boardman; Abigail McNiven; Louise Locock; Lisa Hinton
Journal:  Soc Sci Med       Date:  2021-09-03       Impact factor: 4.634

Review 8.  Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research.

Authors:  Faye Johnson; Fiona Ulph; Rhona MacLeod; Kevin W Southern
Journal:  Eur J Hum Genet       Date:  2022-03-08       Impact factor: 5.351

9.  Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.

Authors:  Stuart G Nicholls; Holly Etchegary; June C Carroll; David Castle; Louise Lemyre; Beth K Potter; Samantha Craigie; Brenda J Wilson
Journal:  BMC Med Genomics       Date:  2016-05-23       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.